Trials / Completed
CompletedNCT00192387
Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)
A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate Viral Shedding in Healthy Children (6 Mos and Less Than or Equal to 18 Months of Age) Vaccinated With Two Doses of Liquid Formulation of Influenza Virus Vaccine, Live Cold Adapted (CAIV-T)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 6 Months – 18 Months
- Healthy volunteers
- Accepted
Summary
The primary objective of this study was to determine the proportion of subjects, seronegative to all three strains of influenza, as defined by a serum hemagglutination inhibition antibodies (HAI) antibody titer of \<1:10, who shed each vaccine virus strain following a single dose of CAIV-T.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CAIV-T, Liquid |
Timeline
- Start date
- 2001-09-01
- Completion
- 2001-12-01
- First posted
- 2005-09-19
- Last updated
- 2021-09-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00192387. Inclusion in this directory is not an endorsement.